Plasminogen Activator Inhibitor-1 4G/5G Promoter Polymorphism in Indian Patients with Deep Vein Thrombosis

• Published in: Indian journal of hematology & blood transfusion 2024-04, Vol.40 (2), p.331-334
• Main Authors: Sharma, Saniya, Jamwal, Manu, Uppal, Varun, Senee, Hari Kishan, Jindal, Manav, Ahluwalia, Jasmina, Das, Reena, Varma, Neelam, Malhotra, Pankaj, Kumar, Narender
• Format: Article
• Language: English
• Subjects: Blood Transfusion Medicine; Genotype & phenotype; Hematology; Human Genetics; Medicine; Medicine & Public Health; Oncology; Polymorphism; Short Communication; Thrombosis
• ISSN: 0971-4502; 0974-0449; 0974-0449; 0971-4502
• DOI: 10.1007/s12288-023-01660-3

A single guanosine deletion/insertion (4G/5G) polymorphism in the promoter region of plasminogen activator inhibitor-1 ( PAI-1 ) gene encoding PAI-1 protein has been investigated in deep vein thrombosis (DVT) patients. The association between PAI-1 4G/5G polymorphism and increased risk of DVT has been reported in some studies, while others have reported a lack of association. The present study aimed to investigate if the PAI-1 4G/5G polymorphism is associated with an increased risk of DVT in the Indian population and to assess its association with thrombophilic risk factors. Fifty-two adult patients with a history of chronic or recurrent DVT and 52 healthy adult controls were genotyped for PAI-1 4G/5G polymorphism. Plasma levels of PAI-1 and other thrombophilic risk factors were also measured.  PAI-1 4G/5G polymorphism was not significantly associated with an increased risk of DVT. Protein C deficiency was significantly associated with the 4G/4G genotype. Patients with the 4G/4G genotype had significantly reduced PAI-1 levels as compared to the controls.  PAI-1 4G/5G polymorphism did not significantly contribute to an increased risk of DVT in the Indian population. However, in the presence of thrombophilic risk factor abnormalities, the risk of DVT is increased in individuals with the 4G/4G genotype in the Indian cohort.